Hepatitis C: When high drug prices preclude patient benefit

Currently, there are at least 6 drug companies that have developed curative treatments for hepatitis C. Drugs that cure hepatitis C can save up to one-half million individuals every year, but these therapies are neither accessible nor affordable. See also pages 000-000.

from Cancer via ola Kala on Inoreader http://ift.tt/2BSV8HI
via IFTTT